The biology of chronic myelogenous leukemia: implications for imatinib therapy.

The biology of chronic myelogenous leukemia: implications for imatinib therapy.

Item
http://www.wikidata.org/entity/Q36733259
The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastomaStudy protocol of the RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia.Long-term outcomes in the second-line treatment of chronic myeloid leukemia: a review of tyrosine kinase inhibitorsTargeted therapy in chronic myeloid leukemia.The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib.Measurement of adherence to BCR-ABL inhibitor therapy in chronic myeloid leukemia: current situation and future challenges.Proteome Changes Induced by Imatinib and Novel Imatinib Derivatives in K562 Human Chronic Myeloid Leukemia CellsMolecular resistance: an early indicator for treatment change?Receptor tyrosine kinase inhibitors: molecularly targeted drugs for veterinary cancer therapy.Imatinib resistance: a review of alternative inhibitors in chronic myeloid leukemia.Pharmacogenetics of tyrosine kinase inhibitors in gastrointestinal stromal tumor and chronic myeloid leukemia.Effects of STAT3 silencing on fate of chronic myelogenous leukemia K562 cells.Healthcare utilization and costs associated with tyrosine kinase inhibitor switching in patients with chronic myeloid leukemia.A single-tube allele specific-polymerase chain reaction to detect T315I resistant mutation in chronic myeloid leukemia patients.Evaluation of healthcare resource utilization and incremental economic burden of patients with chronic myeloid leukemia after disease progression to blast phase.
P2860

The biology of chronic myelogenous leukemia: implications for imatinib therapy.

Item
http://www.wikidata.org/entity/Q36733259
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The biology of chronic myelogenous leukemia: implications for imatinib therapy.
@ast
The biology of chronic myelogenous leukemia: implications for imatinib therapy.
@en
type
label
The biology of chronic myelogenous leukemia: implications for imatinib therapy.
@ast
The biology of chronic myelogenous leukemia: implications for imatinib therapy.
@en
prefLabel
The biology of chronic myelogenous leukemia: implications for imatinib therapy.
@ast
The biology of chronic myelogenous leukemia: implications for imatinib therapy.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
The biology of chronic myelogenous leukemia: implications for imatinib therapy.
@en
P2093
P304
P31
P356
10.1053/J.SEMINHEMATOL.2006.12.007
P433
P478
P50
P577
P698
P921